Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

United Therapeutics Corp (NASDAQ:UTHR)

149.21
Delayed Data
As of Sep 04
 -0.75 / -0.50%
Today’s Change
110.12
Today|||52-Week Range
190.29
+15.23%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line217.9M304.4M174.6M340.1M
 
 
 
 
 
Depreciation20.5M27.1M31.3M32.2M
 
 
 
 
 
Total Other Cash Flow41.6M64.0M331.8M183.4M
 
 
 
 
 
Funds From Operations361.4M531.8M641.9M740.8M
 
 
 
 
 
Funds From/For Other Operating Expenses111.3M208.2M216.7M385.6M
 
 
 
 
 
Net Cash Flow - Operating Activities250.2M323.6M425.3M355.3M
 
 
 
 
 
 
InvestingIncrease In Investments-815.7M-579.3M-793.0M-163.7M
 
 
 
 
 
Decrease In Investments733.9M527.9M529.9M549.6M
 
 
 
 
 
Capital Expenditures-36.0M-111.9M-31.9M-47.4M
 
 
 
 
 
Net Assets From Acquisitions -3.5M0.000.000.00
 
 
Other Investing - Uses-1.0K0.000.000.00
 
 
Net Cash Flow Investing-121.3M-163.4M-295.0M338.5M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings242.5M0.000.00140.0M
 
 
 
Long Term Debt Reduction-251.0M-999.0K-1.3M-317.8M
 
 
 
 
 
Net Proceeds Stock Sale24.4M16.8M29.3M53.5M
 
 
 
 
 
Common Preferred Redeemed0.00-188.0M-42.4M-483.1M
 
 
 
 
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing11.3M3.1M9.3M30.8M
 
 
 
 
 
Other Uses - Financing245.3M0.000.000.00
 
 
Net Cash Flow - Financing-218.1M-169.1M-5.1M-576.5M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-269.0K229.0K-319.0K-3.8M
 
 
 
 
 
 
Net Change In Cash-89.2M-8.9M125.2M117.2M